MedTrace Logo

Association of Gestational Cardiovascular Health With Pregnancy Outcomes

NCT05776082 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-12-29

No results posted yet for this study

Summary

Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.

Conditions

  • Pregnant Women

Interventions

OTHER

Questionnaire survey and specimen collection

Questionnaire survey, clinical follow-up and specimens collection.

Sponsors & Collaborators

  • Women's Hospital School Of Medicine Zhejiang University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China
  • Rwanda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05776082 on ClinicalTrials.gov